Sign in
Active, not recruitingNo phase

Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty. A Single-center, Single-blind Randomized Controlled Trial

Key facts

Who runs it
Azienda Ospedaliero-Universitaria di Parma
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people enrolled
Started
5 Jan 2022
Ended
30 Sept 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • PTA planning supported by 3D-printed model
  • PTA (Standard of Care)
Record updated
2 June 2025

Who can take part

Age
18 years to 89 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age between 18 and 89 years
  • Severe claudication or critical limb ischemia (Rutherford categories 3-5 [Cronenwett and Johnston. Rutherford's Vascular Surgery 7th edition. Saunders Elsevier 2010]) and indication already established for endovascular revascularization treatment (according to the current Italian SICVE guidelines)
  • Atherosclerotic disease involving the aorto-iliac-femoro-popliteal segment
  • Signed informed consent

Who cannot take part

  • Atherosclerotic disease limited to tibial vessels only (absent or non-significant atherosclerosis at aorto-iliac-femoro-popliteal level)
  • Age <18 years or >89 years
  • Preoperative CTA not available for any reason (clinical contraindication, logistical impossibility)
  • Patients requiring urgent intervention (lack of time for 3D model printing)
  • Patient refusal to participate in the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Lower extremity peripheral arterial disease is a major health problem. Currently, balloon angioplasty represents the most commonly performed treatment for patients affected by vascular claudication or critical limb ischemia. Pre-operative planning for aorto-iliac-femoral-popliteal atherosclerotic disease is a complex procedure, since an inappropriate strategy may lead to peri-operative complications. The aim of this study is to propose an innovative planning strategy for balloon angioplasty with the support of complex 3D printed models. The goal is to reduce peri-operative complications and overall costs, while improving technical success and mid-term patency of revascularizations.

The 2 groups in the trial

  • Preoperative planning performed based on CTA (standard of care)Existing treatment, for comparison

    Treatment: PTA (Standard of Care)

  • Preoperative planning performed using CTA and a patient-specific, custom-made 3D-printed modelTreatment being tested

    Treatment: PTA planning supported by 3D-printed model

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty: Applicability, Effectiveness in Technical Success and on Mid-Term Outcomes, Cost-Analysis, and Exploration of New Technologies. A Single-center, Single-blind Randomized Controlled Trial
Publications
Record updated
2 June 2025